“Clone-specific” antibody-drug conjugates: an innovative strategy in the treatment of T-cell cancers
Crossref DOI link: https://doi.org/10.1038/s41392-024-01945-7
Published Online: 2024-09-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Jungherz, Dennis
Lückemeier, Philipp
Herling, Marco
Text and Data Mining valid from 2024-09-04
Version of Record valid from 2024-09-04
Article History
Received: 21 May 2024
Revised: 13 July 2024
Accepted: 31 July 2024
First Online: 4 September 2024
Competing interests
: The authors declare no competing interests.